如果您對這些純文本內容做了任何改變,很快就會看到。

研究成果

  • 717 引文
  • 15 h-指數
  • 27 文章
  • 1 快報
篩選
文章
2020

Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours

de Bono, J., Lin, C. C., Chen, L. T., Corral, J., Michalarea, V., Rihawi, K., Ong, M., Lee, J. H., Hsu, C. H., Yang, J. C. H., Shiah, H. S., Yen, C. J., Anthoney, A., Jove, M., Buschke, S., Fuertig, R., Schmid, U., Goeldner, R. G., Strelkowa, N., Huang, D. C. L. 及其他3, Bogenrieder, T., Twelves, C. & Cheng, A. L., 四月 28 2020, 於 : British Journal of Cancer. 122, 9, p. 1324-1332 9 p.

研究成果: 雜誌貢獻文章

開啟存取
2018

Effective Sirolimus Treatment for Refractory Spindle Cell Haemangioma

Ho, C. B., Hsieh, K., Chen, W. Y., Lin, Y. T., Chiou, J. F., Lee, H. L. & Shiah, H. S., 五月 11 2018, 於 : British Journal of Dermatology.

研究成果: 雜誌貢獻文章

5 引文 斯高帕斯(Scopus)
2016

Effects of Dang-Gui-Bu-Xue-Tang, an herbal decoction, on iron uptake in iron-deficient anemia

Huang, G. C., Chen, S. Y., Tsai, P. W., Ganzon, J. G., Lee, C. J., Shiah, H. S. & Wang, C. C., 三月 2 2016, 於 : Drug Design, Development and Therapy. 10, p. 949-957 9 p.

研究成果: 雜誌貢獻文章

7 引文 斯高帕斯(Scopus)
2015

A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer

Chen, J. S., Hsu, C., Chiang, N. J., Tsai, C. S., Tsou, H. H., Huang, S. F., Bai, L. Y., Chang, I. C., Shiah, H. S., Ho, C. L., Yen, C. J., Lee, K. D., Chiu, C. F., Rau, K. M., Yu, M. S., Yang, Y., Hsieh, R. K., Chang, J. Y., Shan, Y. S., Chao, Y. 及其他13, Chen, L. T., Chin, Y. H., Chung, T. R., Yu, W. L., Lee, M. H., Lin, L. F., Lin, P. C., Wu, Y. L., Wang, H. L., Lu, L. J., Chen, S. Y., Wu, C. C. & Wei, T. C., 五月 1 2015, 於 : Annals of Oncology. 26, 5, p. 943-949 7 p., mdv035.

研究成果: 雜誌貢獻文章

73 引文 斯高帕斯(Scopus)

Phase i study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients

Chang, T. C., Shiah, H. S., Yang, C. H., Yeh, K. H., Cheng, A. L., Shen, B. N., Wang, Y. W., Yeh, C. G., Chiang, N. J., Chang, J. Y. & Chen, L. T., 一月 1 2015, 於 : Cancer Chemotherapy and Pharmacology. 75, 3, p. 579-586 8 p.

研究成果: 雜誌貢獻文章

54 引文 斯高帕斯(Scopus)
2014
20 引文 斯高帕斯(Scopus)
2013

Randomised clinical trial: Comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma

Shiah, H. S., Chen, C. Y., Dai, C. Y., Hsiao, C. F., Lin, Y. J., Su, W. C., Chang, J. Y., Whang-Peng, J., Lin, P. W., Huang, J. D. & Chen, L. T., 一月 2013, 於 : Alimentary Pharmacology and Therapeutics. 37, 1, p. 62-73 12 p.

研究成果: 雜誌貢獻文章

43 引文 斯高帕斯(Scopus)
2011

Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors

Kuo, C. C., Wu, T., Chen, L. T., Shiah, H. S., Wu, C. M., Cheng, Y. T., Pan, W. Y., Liu, J. F., Chen, K. L., Yang, Y. N., Chen, S. N. & Chang, J. Y., 十二月 15 2011, 於 : Free Radical Biology and Medicine. 51, 12, p. 2195-2209 15 p.

研究成果: 雜誌貢獻文章

13 引文 斯高帕斯(Scopus)

Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy

Teng, C. F., Wu, H. C., Tsai, H. W., Shiah, H. S., Huang, W. & Su, I. J., 十月 1 2011, 於 : Hepatology. 54, 4, p. 1199-1207 9 p.

研究成果: 雜誌貢獻文章

40 引文 斯高帕斯(Scopus)
2009

Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer

Ch'ang, H. J., Huang, C. L., Wang, H. P., Shiah, H. S., Chang, M. C., Jan, C. M., Chen, J. S., Tien, Y. W., Hwang, T. L., Lin, J. T., Cheng, A. L., Whang-Peng, J. & Chen, L. T., 十一月 2009, 於 : Cancer Chemotherapy and Pharmacology. 64, 6, p. 1173-1179 7 p.

研究成果: 雜誌貢獻文章

9 引文 斯高帕斯(Scopus)
2007

D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation

Juang, S. H., Lung, C. C., Hsu, P. C., Hsu, K. S., Li, Y. C., Hong, P. C., Shiah, H. S., Kuo, C. C., Huang, C. W., Wang, Y. C., Huang, L., Chen, T. S., Chen, S. F., Fu, K. C., Hsu, C. L., Lin, M. J., Chang, C. J., Ashendel, C. L., Chan, T. C. K., Chou, K. M. 及其他1, Chang, J. C., 一月 1 2007, 於 : Molecular Cancer Therapeutics. 6, 1, p. 193-202 10 p.

研究成果: 雜誌貢獻文章

43 引文 斯高帕斯(Scopus)

Mitochondria-mediated and p53-associated apoptosis induced in human cancer cells by a novel selenophene derivative, D-501036

Shiah, H. S., Lee, W. S., Juang, S. H., Hong, P. C., Lung, C. C., Chang, C. J., Chou, K. M. & Chang, J. Y., 三月 1 2007, 於 : Biochemical Pharmacology. 73, 5, p. 610-619 10 p.

研究成果: 雜誌貢獻文章

51 引文 斯高帕斯(Scopus)

Tamoxifen accelerates proteasomal degradation of O6- methylguanine DNA methyltransferase in human cancer cells

Kuo, C. C., Liu, J. F., Shiah, H. S., Li-Chen, M. & Chang, J. Y., 十一月 15 2007, 於 : International Journal of Cancer. 121, 10, p. 2293-2300 8 p.

研究成果: 雜誌貢獻文章

21 引文 斯高帕斯(Scopus)
2006

Abrogation of skin disease in lupus-prone MRL/Faslpr mice by means of a novel tylophorine analog

Choi, J. Y., Gao, W., Odegard, T., Shiah, H. S., Kashgarian, M., McNiff, J. M., Baker, D. C., Cheng, Y. C. & Craft, J., 十月 1 2006, 於 : Arthritis and Rheumatism. 54, 10, p. 3277-3283 7 p.

研究成果: 雜誌貢獻文章

34 引文 斯高帕斯(Scopus)

Effects of a novel tylophorine analog on collagen-induced arthritis through inhibition of the innate immune response

You, X., Pan, M., Gao, W., Shiah, H. S., Tao, J., Zhang, D., Koumpouras, F., Wang, S., Zhao, H., Madri, J. A., Baker, D., Cheng, Y. C. & Yin, Z., 三月 1 2006, 於 : Arthritis and Rheumatism. 54, 3, p. 877-886 10 p.

研究成果: 雜誌貢獻文章

45 引文 斯高帕斯(Scopus)

Inhibition of cell growth and nuclear factor-κB activity in pancreatic cancer cell lines by a tylophorine analogue, DCB-3503

Shiah, H. S., Gao, W., Baker, D. C. & Cheng, Y. C., 十月 1 2006, 於 : Molecular Cancer Therapeutics. 5, 10, p. 2484-2493 10 p.

研究成果: 雜誌貢獻文章

44 引文 斯高帕斯(Scopus)

Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma

Shiah, H. S., Chao, Y., Chen, L. T., Yao, T. J., Huang, J. D., Chang, J. Y., Chen, P. J., Chuang, T. R., Chin, Y. H., Whang-Peng, J. & Liu, T. W., 一月 1 2006, 於 : Cancer Chemotherapy and Pharmacology. 58, 5, p. 654-664 11 p.

研究成果: 雜誌貢獻文章

11 引文 斯高帕斯(Scopus)

Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer

Shiah, H. S., Cheng, A. L., Hsu, C., Hsu, C. H., Liu, T. W., Chang, J. Y., Jan, C. M., Chao, Y., Yu, W. L., Chuang, T. R., Whang-Peng, J. & Chen, L. T., 一月 1 2006, 於 : Journal of Gastroenterology and Hepatology (Australia). 21, 3, p. 531-536 6 p.

研究成果: 雜誌貢獻文章

5 引文 斯高帕斯(Scopus)

Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer

Ch'ang, H. J., Wang, C. C., Cheng, A. L., Hsu, C., Lu, Y. S., Chang, M. C., Lin, J. T., Wang, H. P., Shiah, H. S., Liu, T. W., Chang, J. Y., Whang-Peng, J. & Chen, L. T., 一月 1 2006, 於 : Journal of Gastroenterology and Hepatology (Australia). 21, 5, p. 874-879 6 p.

研究成果: 雜誌貢獻文章

5 引文 斯高帕斯(Scopus)
2005

Pulmonary embolism after transcatheter arterial chemoembolization

Shiah, H. S., Liu, T. W., Chen, L. T., Chang, J. Y., Liu, J. M., Chuang, T. R., Lee, W. S. & Whang-Peng, J., 十二月 1 2005, 於 : European Journal of Cancer Care. 14, 5, p. 440-442 3 p.

研究成果: 雜誌貢獻文章

12 引文 斯高帕斯(Scopus)

α-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma

Chen, L. T., Liu, T. W., Chao, Y., Shiah, H. S., Chang, J. Y., Juang, S. H., Chen, S. C., Chuang, T. R., Chin, Y. H. & Whang-Peng, J., 八月 1 2005, 於 : Alimentary Pharmacology and Therapeutics. 22, 3, p. 217-226 10 p.

研究成果: 雜誌貢獻文章

31 引文 斯高帕斯(Scopus)
2004

Prognostic implications of the expression of erbB2, topoisomerase IIα and thymidylate synthase in metastatic gastric cancer after fluorouracil-based therapy

Liu, J. M., Chen, L. T., Li, A. F. Y., Wu, C. W., Lan, C., Chung, T. R., Shiah, H. S., Lee, K. D., Liu, T. W. & Peng, J. W., 2004, 於 : Japanese Journal of Clinical Oncology. 34, 12, p. 727-732 6 p.

研究成果: 雜誌貢獻文章

12 引文 斯高帕斯(Scopus)
2002

A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer

Chen, L. T., Liu, T. W., Wu, C. W., Chung, T. R., Shiah, H. S., Jan, C. M., Ming Liu, J., Whang-Peng, J. & Chang, J. Y., 十二月 1 2002, 於 : Oncology. 63, 3, p. 239-247 9 p.

研究成果: 雜誌貢獻文章

17 引文 斯高帕斯(Scopus)

Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23

Shiah, H. S., Kuo, Y. Y., Tang, J. L., Huang, S. Y., Yao, M., Tsay, W., Chen, Y. C., Wang D.-T., M. H. A. S., Lin, K. H. & Tien, H. F., 一月 1 2002, 於 : Leukemia. 16, 2, p. 196-202 7 p.

研究成果: 雜誌貢獻文章

77 引文 斯高帕斯(Scopus)
1991

Modulatory effect of crocetin on aflatoxin B1 cytotoxicity and DNA adduct formation in C3H10T 1 2 fibroblast cell

Wang, C. J., Shiah, H. S. & Lin, J. K., 一月 1 1991, 於 : Cancer Letters. 56, 1, p. 1-10 10 p.

研究成果: 雜誌貢獻文章

36 引文 斯高帕斯(Scopus)